Grigorii Gennadievich Kudriashov

Grigorii Gennadievich Kudriashov

Auto-generated profile, based on publicly available information

Grigorii Gennadievich Kudriashov

Saint Petersburg Research Institute of Phthisiopulmonology

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Молекулярная медицина
Verified
Journal Article
Closed access
IKIuliia Krylova
Iuliia Krylova
GKGrigorii Gennadievich Kudriashov
Grigorii Gennadievich Kudriashov
ANAndrey Olegovich Nefedov
Andrey Olegovich Nefedov
MDMikhail Alexandrovich Dokhov
Mikhail Alexandrovich Dokhov
AZAleksandra Olegovna Zakharchenko
Aleksandra Olegovna Zakharchenko
PYPiotr Kazimirovich Yablonskii
Piotr Kazimirovich Yablonskii
Обзор посвящен анализу современных представлений о молекулярных механизмах опухолевой трансформации при туберкулезе; описаны сигнальные молекулы, возможно являющиеся биомаркерами и мишенями для оптимизации персонифицированной диагностики и таргетной терапии заболевания. Целью исследования было определить современное состояние вопроса и охарактеризовать молекулярные маркеры опухолевой трансформации при туберкулезе. Материал и методы: анализ и систематизация научной литературы за последние 10 лет выполнен в базах данных PubMed, Scopus и Google Scholar. Результаты: особое внимание в обзоре уделено факторам, способствующим опухолевой трансформации при туберкулезе. Рассматриваются как прямые эффекты микобактерии туберкулеза на пролиферацию и иммунный ответ, так и опосредованные механизмы воздействия на клетки, участвующие в процессах воспаления. Обосновывается выбор сигнальных молекул для оптимизации персонифицированной диагностики опухолевой трансформации при...

20 June 2021 in Innovative Medicine of Kuban
Verified
Journal Article
Open access
PDF file
ИВИ. В. Васильев
И. В. Васильев
IZI. A. Zaitcev
I. A. Zaitcev
GKG. G. Kudriashov
G. G. Kudriashov
VLV. F. Lee
V. F. Lee
TNT. A. Novitskaya
T. A. Novitskaya
PYP. K. Yablonskiy
P. K. Yablonskiy
ObjectiveTransbronchial endosonography (EBUS) is a relatively new method for diagnosing of the pathological condition of the thoracic organs. Analysis of 10 years of our experience in the use of transbronchial endosonography in a specialized center.Material and MethodsDuring the period from April 2010 to April 2020, 756 transbronchial endosonographies were conducted on 756 patients. The studies were carried out for various indications: 1) Group 1 (483) – transbronchial puncture of the lymph nodes in order to obtain morphological confirmation of the etiology; 2) Group 2 (260) – staging of suspected or verified lung cancer to determine the descriptor N; 3) Group 3 (13) – a study that ended only with obtaining an endosonographic image. All patients underwent transbronchial endosonography using the special ultrasound bronchoscope EB-1970UK (Pentax Corp.) and the ultrasound scanner EUB 5000 Plus G OB/GYN – Vascular Ultrasound (HITACHI Corp.).ResultsGeneral information content was 78%; verification of mediastinal lymphadenopathy was 72% (57, 79, 58% for smears, cytoblocks and smears + cytoblocks, cytoblocks vs smears + cytoblocks, p < 0.05). Verification of local changes in the mediastinum – 66%; verification of peribronchial tumor – 87%. Lung cancer staging – 87% (82, 88, 86% for smears, cytoblocks vs smears + cytoblocks, respectively, р > 0.05)ConclusionТhe diagnostic utility of EBUS for the verification of mediastinal lymphadenopathy can range from 37,5 to 83% and rise with increasing experience for all persons involved. The use of cytoblocks showed the best results. The diagnostic utility of staging varies from 60 to 100% and does not depend on the method of processing the aspiration material.

7 March 2022 in Grekov's Bulletin of Surgery
Verified
Journal Article
Open access
PDF file
AAA. O. Avetisyan
A. O. Avetisyan
ISI. S. Serezvin
I. S. Serezvin
GKG. G. Kudriashov
G. G. Kudriashov
ACA. V. Chausov
A. V. Chausov
EDE. A. Davydenkova
E. A. Davydenkova
PYP. K. Yablonskii
P. K. Yablonskii
INTRODUCTION. Drug-resistant tuberculosis with subtotal and total lesion of one of the lungs is the most common indication for pneumonectomy. This operation is accompanied by a high risk of postoperative complications, among which the most dangerous is pleural empyema with bronchopleural fistula. In this regard, the prevention of this complication is an extremely important task.TheOBJECTIVEwas to study the results of using a diaphragmatic flap to prevent the development of right main bronchus stump insufficiency with bronchopleural fistula in patients with destructive pulmonary tuberculosis. METHODS AND MATERIALS. A retrospective study was carried out for the period from 2015 to 2019. The study included 13 patients who underwent right-sided pneumonectomy with diaphragmoplasty of the right main bronchus stump. Indications for diaphragmoplasty were: persistent bacterial excretion at the time of surgery, pre-existing bronchopleural fistula, intraoperative pleural contamination, progressive course of a specific process.RESULTS. The postoperative period was smooth in 10 (77 %) patients. Postoperative complications developed in 3 (23 %) patients: in 1 (7.7 %) case, there was right main bronchus stump insufficiency with bronchopleural fistula and in 2 (15.3 %) cases, there were right main bronchus stump insufficiency without bronchopleural fistula. A satisfactory immediate result was achieved in 12 (92.3 %) patients.CONCLUSION. The diaphragmatic flap is a reliable material for plasty of the right main bronchus stump in order to prevent the formation of bronchopleural fistula in destructive pulmonary tuberculosis.

2 November 2025 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
GAG. M. Agafonov
G. M. Agafonov
GKG. G. Kudriashov
G. G. Kudriashov
IKIuliia Krylova
Iuliia Krylova
TZT. S. Zubareva
T. S. Zubareva
IKIgor Kvetnoy
Igor Kvetnoy
PYP. K. Yablonskiy
P. K. Yablonskiy
Introduction . The mechanisms of interaction between lung cancer and tuberculosis (TB) are not fully understood. The aim of the study is to study the effect of pulmonary tuberculosis on the lung cancer. Materials and methods . The study utilized a model (Patent RU 2800964 C1) of isolated Lewis lung carcinoma (LLC) and generalized TB (H37Rv and 5582 strains) in C57BL/6 mice. Five groups of laboratory animals were formed: isolated tuberculosis (different M. tuberculosis susceptibility), isolated LLC, and 2 groups with combined pathology. An immunohistochemical analysis for TNF-α, PCNA, and MMP-9 was completed. Results . The relative expression of MMP-9 in the groups with combined pathology was significantly lower than in the isolated tumor group: LLC + H37Rv — 2.60; LLC + 5582–3.00; LLC — 8.90 ( p = 0.043). The relative expression of TNF-α showed no statistically significant differences between the combined pathology groups and the isolated tumor group: LLC + H37Rv — 1.35; LLC + 5582–3.70; LLC — 1.70. A statistically significant increase in TNF-α expression was observed in mice infected with the drug-resistant M. tuberculosis strain (5582). The relative expression of PCNA was significantly lower in the combined pathology groups compared to the isolated tumor group: LLC + H37Rv — 8.50; LLC + 5582 — 14.30; LLC — 36.45 ( p = 0.012). Discussion . Data demonstrated that TB led to the suppression of tumor-induced MMP-9 expression, reduction in PCNA expression. This may indicate the suppression of metastasisе, cell proliferation. The TNF-α expression level didn`t differ significantly between the groups. Conclusion . The obtained data may suggest an oncosuppressive effect of tuberculosis on the lung tumors.

17 November 2025 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
GAGeorgiy M. Agafonov
Georgiy M. Agafonov
GKGrigorii G. Kudriashov
Grigorii G. Kudriashov
PYPetr K. Yablonskiy
Petr K. Yablonskiy
КГКудряшов Григорий Геннадьевич
Кудряшов Григорий Геннадьевич
Background. Lung cancer and tuberculosis are among the leading causes of morbidity and mortality, both within the categories of oncological and infectious diseases and among all pathological conditions of the human. Aim. To show the features of the clinical course, preoperative diagnosis, and surgical treatment in patients with concurrent lung cancer and tuberculosis across different age groups. Materials and methods. A retrospective analysis of data from 69 patients with concurrent lung cancer and tuberculosis observed between 2002 and 2024, divided into 7 age groups (44 years, 45–49 years, 50–54 years, 55–59 years, 60–64 years, 65–69 years, and ≥70 years). Results. The time from symptom onset to hospitalization, clinical presentation, comorbidity (Charlson index), pulmonary function test results, characteristics of the tuberculosis process and M. tuberculosis susceptibility, extent of surgical intervention, duration of postoperative recovery, and frequency of postoperative complications showed no statistically significant difference. Younger and middle-aged patients more frequently exhibited mediastinal lymphadenopathy on CT scans, central squamous cell carcinoma with mediastinal lymph node involvement in combination with active tuberculosis, and a higher rate of postoperative complications. In contrast, older patients more often had intact or calcified intrathoracic lymph nodes on CT scans, peripheral adenocarcinomas at an early stage of malignancy, frequently against a background of post-tuberculosis changes. Conclusion. Concurrent lung cancer and tuberculosis manifest, are diagnosed, and have different life expectancy prognoses depending on the age at diagnosis.

16 May 2024 in Grekov's Bulletin of Surgery
Verified
Journal Article
Open access
PDF file
AAA. O. Avetisyan
A. O. Avetisyan
ISI. S. Serezvin
I. S. Serezvin
GKG. G. Kudriashov
G. G. Kudriashov
PYP. K. Yablonskii
P. K. Yablonskii
INTRODUCTION. One of the most formidable complications in thoracic surgery is bronchopleural fistula after pneumonectomy. Main bronchus stump reinforcement during surgery is used as method of prevention of this complication. The question of the preferred plastic material remains debatable.The OBJECTIVE was to compare the results of myoplasty and diaphragmoplasty of the right main bronchus stump after pneumonectomy performed for destructive pulmonary tuberculosis.METHODS AND MATERIALS. A retrospective study from 2015 to 2022 was conducted. The study included 30 patients who were divided into 2 groups. Group 1 included 19 patients who underwent diaphragmoplasty; group 2 included 11 patients who underwent myoplasty. Patients were comparable in terms of sex, age, functional indices, and features of the course and prevalence of the underlying disease. The short-term and long-term results of surgical treatment were compared.RESULTS. Complicated course of the postoperative period was observed in 6 (31.6 %) patients in group 1 and in 5 (45.5 %) patients in group 2. Satisfactory immediate result in group 1 was achieved in 17 (89.5 %) patients, in group 2 – in 8 (72.7 %). In the remote period, the result of complex treatment of TB patients in group 1: successful treatment – 13 (68.5 %), ineffective treatment – 2 (10.5 %), loss to follow-up – 2 (10.5 %), lethal outcome – in 2 (10.5 %); in group 2: successful treatment – 8 (72.7 %), ineffective treatment – in 3 (27.3 %).CONCLUSIONS. Right-sided pneumonectomy in patients with destructive pulmonary tuberculosis with drug-resistant mycobacteria is accompanied by a high risk of main bronchus stump failure. The diaphragm and chest wall muscles are reliable materials for strengthening the main bronchus stump.